General description
  Amoxicillin is an extended spectrum penicillin antibiotic.  Clavulanic acid is a beta-lactamase inhibitor.
INN
  Amoxicillin + clavulanic acid
ATC codes
  
Medicine type
  Chemical agent
Antibiotic groups
  
EML status history
  
    First added in 1997
     
      (TRS
        882)
         
      for 
        Bacterial infection of unspecified site
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Acute otitis media
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Infectious cystitis
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Chronic obstructive pulmonary disease with acute exacerbation
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Acute sinusitis
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Bacterial cellulitis, erysipelas or lymphangitis
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Osteomyelitis or osteitis
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Bacterial infection of joint
      
      
  
    Removed in 2017
     
      (TRS
        1006)
         
      for 
        Bacterial infection of unspecified site
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Neutropenia
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Peritoneal abscess
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Peritonitis
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Bacterial pneumonia
      
      
  
    Added in 2017
     
      (TRS
        1006)
         
      for 
        Other specified pneumonia
      
      
  
    Added in 2019
     
      (TRS
        1021)
         
      for 
        Other specified prophylactic measures
      
      
  
    Added in 2019
     
      (TRS
        1021)
         
      for 
        Multi-drug resistant Mycobacterium tuberculosis
      
      
Wikipedia
  
DrugBank
  
Recommendations
  
          Section
        
        Access group antibiotics
      - Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
- Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)
- Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
- Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
- Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
        Indications
      
            First choice
Peritonitis (mild-moderate) Bacterial pneumonia (Community-acquired pneumonia - severe) [children] Other specified pneumonia (Hospital-acquired pneumonia) Peritoneal abscess (mild-moderate) Neutropenia (low-risk) Infectious cystitis Acute sinusitis Bacterial cellulitis, erysipelas or lymphangitis Chronic obstructive pulmonary disease with acute exacerbation
          Other indications
        
                    
    
          Section
        
        Antituberculosis medicines
      - Oral > Liquid: 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
- Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)
        Indications